NEW YORK (GenomeWeb) – Insilico Medicine said this week that it will integrate unspecified data assets as well as the staff of InSilico Screen, a Belgian bioinformatics company that provides tools for dynamic signaling modelling and scalable molecular simulations.

Under the terms of the agreement, InSilico Screen Founder and CEO Quentin Vanhaelen will join Insilico Medicine as the head of the so-called "almost human" team. He will split his time between Baltimore, where InSilico Medicine has an office, and Brussels, where InSilico Screen is located.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.

Mar
13
Sponsored by
Agilent

This webinar will share how clinical genetics labs can integrate cytogenetics and molecular data to assess abnormalities using a single sample on a single workflow platform.